NuCana (NCNA) EBIT (2017 - 2025)

NuCana has disclosed EBIT across 9 years of filings, most recently posting -$3.7 million for Q4 2025.

• EBIT for Q4 2025 came in at -$3.7 million, down 235.47% year-over-year; the trailing twelve-month figure through Dec 2025 was -$24.1 million (up 16.9% YoY), and the FY2025 annual result was -$26.5 million, up 9.06% from the prior year.
• EBIT came in at -$3.7 million for Q4 2025 at NuCana, down from -$1.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$1.1 million in Q3 2025 to a low of -$21.2 million in Q4 2021.
• The 5-year median for EBIT is -$10.5 million (2024), against an average of -$10.4 million.
• Across the five-year window, EBIT jumped 90.18% in 2024 and plunged 235.47% in 2025, its largest moves.
• NuCana's EBIT stood at -$21.2 million in 2021, then increased by 4.63% to -$20.2 million in 2022, then jumped by 44.13% to -$11.3 million in 2023, then surged by 90.18% to -$1.1 million in 2024, then slumped by 235.47% to -$3.7 million in 2025.
• The last three EBIT figures came in at -$3.7 million (Q4 2025), -$1.1 million (Q3 2025), and -$15.8 million (Q2 2025), per Business Quant data.